University of Texas-MD Anderson Cancer Center: New Biomarker-Guided Strategy Has Potential for Liver Cancer Treatment
July 16, 2019
July 16, 2019
HOUSTON, Texas, July 16 [TNSscienceresearch] -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
- Blocking IL-6 pathway may extend duration of immunotherapy and reduce side effects
* * *
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with . . .
* * *
- Blocking IL-6 pathway may extend duration of immunotherapy and reduce side effects
* * *
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with . . .